Xenon Pharmaceuticals XENE
NASDAQ XENE
$38.02 -0.91 (-2.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xenon Pharmaceuticals (XENE) Non Operating Investment Income (2021 - 2022)

Updated

Xenon Pharmaceuticals (XENE) posted Non Operating Investment Income of -$1.29 million for Q2 2022, compared with -$17,000 a year earlier.

Analysis

Xenon Pharmaceuticals (XENE) Non Operating Investment Income (2021 - 2022) Analysis & Trends

For the trailing twelve months through Jun 30, 2022, Non Operating Investment Income at Xenon Pharmaceuticals was -$4.74 million; for FY2021, it was -$719,000.

  • In prior years, Xenon Pharmaceuticals' Non Operating Investment Income was $4,000 in FY2020.
  • Quarterly Non Operating Investment Income has run from a low of -$3.36 million in Q1 2022 to a high of -$17,000 in Q2 2021 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Xenon Pharmaceuticals 3.68 Bn 3.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -1.29 Mn
Mar 31, 2022 -3.36 Mn
Jun 30, 2021 -17,000.00
Mar 31, 2021 -74,000.00
API Access

Xenon Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=XENE&period=max&api_key=YOUR_API_KEY